ANRO Alto Neuroscience, Inc.

Fundamentals / CIK 0001999480 / USD

Alto Neuroscience, Inc. reported $326.5M in total assets and a net loss of $95.18M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ANRO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$0$0$0-$59.13MFY 2023 Net Income: -$36.30M2023FY 2024 Net Income: -$61.43M2024FY 2025 Net Income: -$63.24M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $45.62M $47.00M $30.29M
Total Operating Expenses $66.36M $68.61M $37.81M
Operating Income -$66.36M -$68.61M -$37.81M
EBITDA -$65.70M -$68.11M -$37.44M
Interest Income $6.60M $8.85M $2.35M
Interest Expense $2.47M $1.38M $1.37M
Income Tax Expense $0 $0 $0
Net Income -$63.24M -$61.43M -$36.30M
Basic EPS -$2.19 -$2.50 -$9.73
Diluted EPS -$2.19 -$2.50 -$9.73
Basic Shares Outstanding 28.9M 24.6M 3.7M
Diluted Shares Outstanding 28.9M 24.6M 3.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $18.16M $22.11M $20.29M $12.00M $10.53M $13.12M $9.97M $10.80M
Total Operating Expenses $27.23M $29.13M $27.14M $17.05M $14.95M $18.68M $15.68M $17.00M
Operating Income -$27.23M -$29.13M -$27.14M -$17.05M -$14.95M -$18.68M -$15.68M -$17.00M
EBITDA -$27.12M -$28.93M -$26.95M -$16.90M -$14.75M -$18.58M -$15.51M -$16.83M
Interest Income $2.60M $2.11M $1.56M $1.56M $1.53M $1.68M $1.83M $2.13M
Interest Expense $463K $491K $545K $575K $650K $646K $598K $333K
Income Tax Expense -- -- -- $0 $0 $0 $0 $0
Net Income -$25.12M -$27.64M -$26.24M -$16.18M -$14.18M -$17.71M -$15.17M -$15.20M
Basic EPS -$0.54 -$0.65 -$0.80 -- -$0.52 -$0.65 -$0.56 --
Diluted EPS -$0.54 -$0.65 -$0.80 -- -$0.52 -$0.65 -$0.56 --
Basic Shares Outstanding 46.5M 42.8M 32.9M -- 27.1M 27.1M 27.0M --
Diluted Shares Outstanding 46.5M 42.8M 32.9M -- 27.1M 27.1M 27.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $176.5M $168.2M $82.55M
Cash & Short-Term Investments $176.5M $168.2M $82.55M
Other Current Assets -- $30K $112K
Total Current Assets $177.7M $169.3M $85.39M
Property, Plant & Equipment, Net $1.87M $2.67M $1.11M
Total Non-Current Assets $6.97M $8.21M $1.24M
Total Assets $184.7M $177.5M $86.63M
Accounts Payable $1.88M $1.58M $1.07M
Short-Term Debt $585K $0 $0
Total Current Liabilities $11.32M $10.01M $5.61M
Long-Term Debt $16.17M $10.25M $9.86M
Total Non-Current Liabilities $22.22M $16.07M $11.21M
Total Liabilities $33.55M $26.08M $16.82M
Total Debt (incl. Leases) $21.73M $15.64M $9.99M
Retained Earnings -$201.6M -$138.4M -$76.97M
Accumulated Other Comp. Income $22K -$101K -$79K
Total Stockholders' Equity $151.1M $151.5M -$71.67M
Total Equity $151.1M $151.5M -$71.67M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $319.3M $243.7M $263.8M $176.5M $137.8M $147.6M $160.8M $168.2M
Cash & Short-Term Investments $319.3M $243.7M $263.8M $176.5M $137.8M $147.6M $160.8M $168.2M
Other Current Assets -- -- -- -- -- -- $23K $30K
Total Current Assets $323.2M $247.3M $269.1M $177.7M $139.4M $149.8M $163.5M $169.3M
Property, Plant & Equipment, Net $1.87M $2.05M $2.23M $1.87M $2.03M $2.31M $2.48M $2.67M
Total Non-Current Assets $3.31M $6.75M $7.13M $6.97M $7.56M $8.03M $8.39M $8.21M
Total Assets $326.5M $254.1M $276.3M $184.7M $147.0M $157.9M $171.9M $177.5M
Accounts Payable $3.47M $4.02M $3.37M $1.88M $2.06M $1.67M $1.38M $1.58M
Short-Term Debt $4.51M $3.77M $2.14M $585K -- -- -- $0
Total Current Liabilities $17.84M $16.65M $13.12M $11.32M $9.04M $8.13M $7.26M $10.01M
Long-Term Debt $8.97M $12.42M $13.88M $16.17M $20.31M $20.12M $19.94M $10.25M
Total Non-Current Liabilities $12.14M $18.16M $19.77M $22.22M $26.40M $26.34M $25.56M $16.07M
Total Liabilities $29.98M $34.82M $32.89M $33.55M $35.45M $34.47M $32.82M $26.08M
Total Debt (incl. Leases) $15.52M $20.83M $20.88M $21.73M $25.40M $25.31M $25.23M $15.64M
Retained Earnings -$280.6M -$255.5M -$227.9M -$201.6M -$185.5M -$171.3M -$153.6M -$138.4M
Accumulated Other Comp. Income $19K $17K $13K $22K $14K $31K $14K -$101K
Total Stockholders' Equity $296.5M $219.2M $243.4M $151.1M $111.6M $123.4M $139.1M $151.5M
Total Equity $296.5M $219.2M $243.4M $151.1M $111.6M $123.4M $139.1M $151.5M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$63.24M -$61.43M -$36.30M
Depreciation & Amortization $661K $502K $373K
Stock-Based Compensation $8.11M $7.63M $2.89M
Change in Payables $221K $516K -$632K
Operating Cash Flow -$51.77M -$47.42M -$33.45M
Capital Expenditure -$24K -$2.08M -$470K
Free Cash Flow -$51.79M -$49.50M -$33.92M
Investing Cash Flow -$24K -$2.08M -$470K
Financing Cash Flow $60.08M $135.7M $68.13M
Net Change in Cash $8.26M $86.18M $34.20M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$25.12M -$27.64M -$26.24M -$16.18M -$14.18M -$17.71M -$15.17M -$15.20M
Depreciation & Amortization $100K $200K $184K $157K $200K $100K $171K $170K
Stock-Based Compensation $3.52M $3.55M $2.82M $1.95M $2.19M $2.00M $1.97M $1.57M
Change in Payables -$544K $652K $1.49M -$297K $461K $323K -$266K -$762K
Operating Cash Flow -$20.76M -$19.76M -$27.09M -$11.52M -$9.92M -$13.78M -$16.56M -$13.02M
Capital Expenditure $0 $0 -$556K $0 $0 $0 -$24K -$506K
Free Cash Flow -$20.76M -$19.76M -$27.65M -$11.52M -$9.92M -$13.78M -$16.58M -$13.53M
Investing Cash Flow $0 $0 -$556K $0 $0 $0 -$24K -$506K
Financing Cash Flow $96.36M -$273K $114.9M $50.19M $153K $613K $9.13M $49K
Net Change in Cash $75.61M -$20.03M $87.28M $38.67M -$9.77M -$13.17M -$7.47M -$13.47M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -41.8% -40.6% --
Return on Assets (ROA) -34.2% -34.6% -41.9%
Current Ratio 15.69x 16.92x 15.22x
Quick Ratio 15.58x 16.81x 14.71x
Debt to Equity 0.14x 0.10x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -32.1% -38.4% -30.5% -41.8% -55.8% -52.6% -45.4% -40.6%
Return on Assets (ROA) -29.2% -33.2% -26.9% -34.2% -42.3% -41.1% -36.8% -34.6%
Current Ratio 18.12x 14.85x 20.52x 15.69x 15.42x 18.43x 22.53x 16.92x
Quick Ratio 17.90x 14.64x 20.11x 15.58x 15.24x 18.16x 22.15x 16.81x
Debt to Equity 0.05x 0.10x 0.09x 0.14x 0.23x 0.21x 0.18x 0.10x
Source: SEC EDGAR CompanyFacts (CIK 0001999480) · from March 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:29 UTC · Open in terminal